216 related articles for article (PubMed ID: 27651009)
1. Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.
Hommet C; Novella JL; Auriacombe S; Vercelletto M; Berrut G; Belliard S; Desmidt T; Ceccaldi M
Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):274-86. PubMed ID: 27651009
[TBL] [Abstract][Full Text] [Related]
2. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
[No Abstract] [Full Text] [Related]
3. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
Desmidt T; Hommet C; Camus V
Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
[TBL] [Abstract][Full Text] [Related]
4. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
[TBL] [Abstract][Full Text] [Related]
5. Drugs for Alzheimer disease.
Can Fam Physician; 2005 Nov; 51(11):1485. PubMed ID: 16353830
[No Abstract] [Full Text] [Related]
6. Memantine for treatment of moderate to severe Alzheimer's disease.
Perras C
Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.
Schneider LS; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M
J Intern Med; 2014 Mar; 275(3):251-83. PubMed ID: 24605808
[TBL] [Abstract][Full Text] [Related]
8. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P
Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637
[TBL] [Abstract][Full Text] [Related]
9. Donepezil plus memantine versus donepezil alone for treatment of concomitant Alzheimer's disease and chronic obstructive pulmonary disease: a retrospective observational study.
Cao Y; Qian L; Yu W; Li T; Mao S; Han G
J Int Med Res; 2020 Feb; 48(2):300060520902895. PubMed ID: 32046559
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis.
Matsunaga S; Kishi T; Iwata N
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25548104
[TBL] [Abstract][Full Text] [Related]
11. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
[TBL] [Abstract][Full Text] [Related]
12. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
[TBL] [Abstract][Full Text] [Related]
13. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil.
van Dyck CH; Schmitt FA; Olin JT;
Am J Geriatr Psychiatry; 2006 May; 14(5):428-37. PubMed ID: 16670247
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
Riordan KC; Hoffman Snyder CR; Wellik KE; Caselli RJ; Wingerchuk DM; Demaerschalk BM
Neurologist; 2011 Mar; 17(2):121-3. PubMed ID: 21364371
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
16. Effectiveness of antidementia drugs in delaying Alzheimer's disease progression.
Rountree SD; Atri A; Lopez OL; Doody RS
Alzheimers Dement; 2013 May; 9(3):338-45. PubMed ID: 23102979
[TBL] [Abstract][Full Text] [Related]
17. The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France.
Touchon J; Lachaine J; Beauchemin C; Granghaud A; Rive B; Bineau S
Eur J Health Econ; 2014 Nov; 15(8):791-800. PubMed ID: 23928827
[TBL] [Abstract][Full Text] [Related]
18. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
Rodda J; Carter J
Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
[No Abstract] [Full Text] [Related]
19. [Cognitive decline in Alzheimer's disease. A follow three or more years of a sample of patients].
Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferràndiz M; Pericot-Nierga I; López-Pousa S
Rev Neurol; 2013 Jun; 56(12):593-600. PubMed ID: 23744245
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of memantine in the treatment of Alzheimer's disease].
Molinuevo Guix JL; Lladó Plarrumaní A
Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
